Vault-13

STEMPOINT CAPITAL LP

NEW YORK, NY · CIK 1952142 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2022 · limited partnership

$577.9m reported value -44.0% vs Q1 2026
73positions
41.2%in top 10
25 new 7 added 41 reduced 22 sold out vs Q1 2026

Options: 5 call positions ($1.9m notional), 6 put positions ($747.5k notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TANGO THERAPEUTICS INC COM TNGX TNGX 1,223,019 $38.2m6.62% 6.62% AddedShares held: Q3 2025 245.4k, Q4 2025 0, Q1 2026 401.8k, Q2 2026 1.2m +821.2k +821,181 204.4%
2 ABIVAX SA SPONSORED ADS ABVX ABVX 283,657 $37.8m6.54% 6.54% ReducedShares held: Q3 2025 166.3k, Q4 2025 391.8k, Q1 2026 627.6k, Q2 2026 283.7k -343.9k -343,925 -54.8%
3 REVOLUTION MEDICINES INC COM RVMD RVMD 159,943 $30.0m5.18% 5.18% ReducedShares held: Q3 2025 185.4k, Q4 2025 62.0k, Q1 2026 563.3k, Q2 2026 159.9k -403.3k -403,321 -71.6%
4 ERASCA INC COM ERAS ERAS 1,565,913 $28.7m4.96% 4.96% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 479.7k, Q2 2026 1.6m +1.1m +1,086,191 226.4%
5 TYRA BIOSCIENCES INC COM TYRA TYRA 632,754 $20.2m3.50% 3.50% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 386.4k, Q2 2026 632.8k +246.4k +246,400 63.8%
6 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 200,851 $19.6m3.39% 3.39% AddedShares held: Q3 2025 41.4k, Q4 2025 79.3k, Q1 2026 171.0k, Q2 2026 200.9k +29.8k +29,847 17.4%
7 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 346,914 $17.6m3.05% 3.05% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 726.9k, Q2 2026 346.9k -380.0k -379,962 -52.3%
8 MINERALYS THERAPEUTICS INC COM MLYS MLYS 602,686 $16.3m2.81% 2.81% ReducedShares held: Q3 2025 158.1k, Q4 2025 290.0k, Q1 2026 1.1m, Q2 2026 602.7k -464.1k -464,070 -43.5%
9 BIOHAVEN LTD COM BHVN BHVN 1,064,200 $15.8m2.74% 2.74% ReducedShares held: Q3 2025 1.0m, Q4 2025 0, Q1 2026 3.2m, Q2 2026 1.1m -2.1m -2,124,782 -66.6%
10 SURROZEN INC COM NEW SRZN SRZN 602,798 $13.8m2.39% 2.39% ReducedShares held: Q3 2025 713.5k, Q4 2025 619.8k, Q1 2026 721.6k, Q2 2026 602.8k -118.8k -118,822 -16.5%
11 KINIKSA PHARMACEUTICALS INTL ORD SHS CL A KNSA KNSA 209,234 $13.4m2.32% 2.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 209.2k
12 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 239,146 $13.2m2.28% 2.28% ReducedShares held: Q3 2025 726.2k, Q4 2025 886.9k, Q1 2026 2.1m, Q2 2026 239.1k -1.8m -1,831,846 -88.5%
13 ALKERMES PLC SHS ALKS ALKS 248,015 $13.0m2.25% 2.25% AddedShares held: Q3 2025 241.6k, Q4 2025 0, Q1 2026 161.0k, Q2 2026 248.0k +87.0k +87,031 54.1%
14 FIRST TRACKS BIOTHERAPEUTICS ORD SHS TRAX TRAX 622,723 $12.5m2.17% 2.17% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 622.7k
15 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 37,243 $12.5m2.16% 2.16% ReducedShares held: Q3 2025 0, Q4 2025 21.1k, Q1 2026 112.5k, Q2 2026 37.2k -75.3k -75,291 -66.9%
16 ROIVANT SCIENCES LTD SHS ROIV ROIV 348,408 $12.3m2.13% 2.13% ReducedShares held: Q3 2025 4.2m, Q4 2025 966.7k, Q1 2026 771.6k, Q2 2026 348.4k -423.2k -423,192 -54.9%
17 BIOAGE LABS INC COM BIOA BIOA 464,171 $11.4m1.97% 1.97% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 677.3k, Q2 2026 464.2k -213.1k -213,137 -31.5%
18 CG ONCOLOGY INC COM CGON CGON 159,349 $11.3m1.96% 1.96% ReducedShares held: Q3 2025 63.0k, Q4 2025 0, Q1 2026 411.2k, Q2 2026 159.3k -251.9k -251,895 -61.2%
19 ORUKA THERAPEUTICS INC COM ORKA ORKA 116,461 $11.1m1.92% 1.92% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 116.5k
20 IMMUNOVANT INC COM IMVT IMVT 276,527 $10.7m1.84% 1.84% ReducedShares held: Q3 2025 1.6m, Q4 2025 645.0k, Q1 2026 1.5m, Q2 2026 276.5k -1.2m -1,216,461 -81.5%
21 CELCUITY INC COM CELC CELC 98,203 $10.3m1.78% 1.78% ReducedShares held: Q3 2025 136.7k, Q4 2025 118.3k, Q1 2026 120.1k, Q2 2026 98.2k -21.9k -21,921 -18.2%
22 RELMADA THERAPEUTICS INC COM RLMD RLMD 1,460,093 $10.1m1.75% 1.75% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.5m +265.3k +265,275 22.2%
23 CLIMB BIO INC COM CLYM CLYM 742,745 $9.7m1.68% 1.68% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 742.7k
24 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 106,926 $9.5m1.64% 1.64% ReducedShares held: Q3 2025 0, Q4 2025 32.4k, Q1 2026 335.2k, Q2 2026 106.9k -228.3k -228,286 -68.1%
25 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 1,368,215 $8.1m1.40% 1.40% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.5m, Q2 2026 1.4m -138.8k -138,825 -9.2%
26 INFLARX NV COM IFRX IFRX 3,228,255 $7.2m1.25% 1.25% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.2m
27 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 384,304 $6.9m1.19% 1.19% ReducedShares held: Q3 2025 276.9k, Q4 2025 565.1k, Q1 2026 1.3m, Q2 2026 384.3k -955.1k -955,066 -71.3%
28 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 178,412 $6.6m1.15% 1.15% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 508.5k, Q2 2026 178.4k -330.1k -330,122 -64.9%
29 OVID THERAPEUTICS INC COM OVID OVID 2,417,283 $6.5m1.13% 1.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.4m
30 EQUILLIUM INC COM EQ EQ 2,016,607 $6.5m1.12% 1.12% NewShares held: Q3 2025 1.9m, Q4 2025 0, Q1 2026 0, Q2 2026 2.0m
31 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 137,124 $6.5m1.12% 1.12% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 651.0k, Q2 2026 137.1k -513.8k -513,842 -78.9%
32 CYTOKINETICS INC COM NEW CYTK CYTK 75,603 $6.4m1.11% 1.11% ReducedShares held: Q3 2025 0, Q4 2025 147.0k, Q1 2026 259.2k, Q2 2026 75.6k -183.6k -183,551 -70.8%
33 DAMORA THERAPEUTICS INC COM NEW COM NEW 216,194 $5.6m0.97% 0.97% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 216.2k
34 INVENTIVA SA ADS IVA IVA 1,426,320 $5.4m0.93% 0.93% NewShares held: Q3 2025 30.8k, Q4 2025 467.2k, Q1 2026 0, Q2 2026 1.4m
35 CENTURY THERAPEUTICS INC COM IPSC IPSC 2,146,182 $5.3m0.91% 0.91% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.1m
36 AURA BIOSCIENCES INC COM AURA AURA 714,280 $5.1m0.88% 0.88% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 714.3k
37 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 338,471 $4.8m0.84% 0.84% ReducedShares held: Q3 2025 0, Q4 2025 353.8k, Q1 2026 1.6m, Q2 2026 338.5k -1.3m -1,283,057 -79.1%
38 ASSEMBLY BIOSCIENCES INC COM NEW ASMB ASMB 170,378 $4.7m0.81% 0.81% ReducedShares held: Q3 2025 66.1k, Q4 2025 156.7k, Q1 2026 370.9k, Q2 2026 170.4k -200.5k -200,492 -54.1%
39 AADI BIOSCIENCE INC COM WHWK WHWK 1,021,037 $4.7m0.81% 0.81% ReducedShares held: Q3 2025 424.1k, Q4 2025 1.5m, Q1 2026 1.9m, Q2 2026 1.0m -857.7k -857,701 -45.6%
40 XENON PHARMACEUTICALS INC COM XENE XENE 76,075 $4.6m0.79% 0.79% ReducedShares held: Q3 2025 192.3k, Q4 2025 348.6k, Q1 2026 281.5k, Q2 2026 76.1k -205.4k -205,435 -73.0%
41 UNIQURE NV SHS QURE QURE 88,115 $4.1m0.70% 0.70% ReducedShares held: Q3 2025 522.2k, Q4 2025 43.5k, Q1 2026 156.1k, Q2 2026 88.1k -68.0k -68,017 -43.6%
42 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 284,769 $4.0m0.70% 0.70% NewShares held: Q3 2025 275.6k, Q4 2025 0, Q1 2026 0, Q2 2026 284.8k
43 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 118,000 $3.9m0.67% 0.67% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 118.0k
44 MAPLIGHT THERAPEUTICS INC COM MPLT MPLT 106,906 $3.8m0.66% 0.66% ReducedShares held: Q3 2025 0, Q4 2025 100.0k, Q1 2026 200.0k, Q2 2026 106.9k -93.1k -93,094 -46.5%
45 ALUMIS INC COM ALMS ALMS 135,736 $3.8m0.66% 0.66% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 459.1k, Q2 2026 135.7k -323.4k -323,396 -70.4%
46 AXSOME THERAPEUTICS INC COM AXSM AXSM 15,375 $3.8m0.65% 0.65% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 15.4k
47 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 153,544 $3.7m0.64% 0.64% NewShares held: Q3 2025 0, Q4 2025 61.6k, Q1 2026 0, Q2 2026 153.5k
48 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 143,167 $3.6m0.63% 0.63% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 485.1k, Q2 2026 143.2k -342.0k -341,965 -70.5%
49 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 358,780 $3.6m0.62% 0.62% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 390.8k, Q2 2026 358.8k -32.0k -32,026 -8.2%
50 PERSONALIS INC COM PSNL PSNL 247,783 $3.3m0.57% 0.57% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 247.8k
51 CRESCENT BIOPHARMA INC. COM CBIO CBIO 182,382 $3.3m0.57% 0.57% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 182.4k
52 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 39,198 $3.2m0.55% 0.55% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 39.2k
53 KODIAK SCIENCES INC COM KOD KOD 75,872 $3.0m0.51% 0.51% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 75.9k
54 PHARVARIS N V COM PHVS PHVS 80,907 $2.8m0.48% 0.48% ReducedShares held: Q3 2025 0, Q4 2025 58.4k, Q1 2026 173.3k, Q2 2026 80.9k -92.4k -92,367 -53.3%
55 MONOPAR THERAPEUTICS INC COM NEW MNPR MNPR 30,125 $2.8m0.48% 0.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 30.1k
56 RAPPORT THERAPEUTICS INC COM RAPP RAPP 66,582 $2.8m0.48% 0.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 66.6k
57 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 77,589 $2.6m0.46% 0.46% ReducedShares held: Q3 2025 150.6k, Q4 2025 73.1k, Q1 2026 361.3k, Q2 2026 77.6k -283.7k -283,727 -78.5%
58 SIONNA THERAPEUTICS INC COM SION SION 59,426 $2.6m0.45% 0.45% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 73.1k, Q2 2026 59.4k -13.7k -13,654 -18.7%
59 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 98,945 $2.6m0.45% 0.45% ReducedShares held: Q3 2025 411.9k, Q4 2025 224.7k, Q1 2026 827.6k, Q2 2026 98.9k -728.6k -728,639 -88.0%
60 C4 THERAPEUTICS INC COM STK CCCC CCCC 523,648 $2.4m0.42% 0.42% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 906.5k, Q2 2026 523.6k -382.8k -382,824 -42.2%
61 SPRUCE BIOSCIENCES INC COM NEW SPRB SPRB 41,388 $2.2m0.39% 0.39% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 12.7k, Q2 2026 41.4k +28.7k +28,668 225.4%
62 CUE BIOPHARMA INC COM CUE CUE 66,995 $2.1m0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 67.0k
63 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 38,178 $2.0m0.35% 0.35% ReducedShares held: Q3 2025 129.3k, Q4 2025 351.1k, Q1 2026 400.5k, Q2 2026 38.2k -362.4k -362,356 -90.5%
64 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 16,303 $2.0m0.35% 0.35% ReducedShares held: Q3 2025 48.0k, Q4 2025 59.4k, Q1 2026 145.2k, Q2 2026 16.3k -128.9k -128,851 -88.8%
65 HELIX ACQUISITION CORP III USD CL A ORD SHS HLXC HLXC 171,671 $1.8m0.32% 0.32% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 610.1k, Q2 2026 171.7k -438.4k -438,385 -71.9%
66 BIODESIX INC COM BDSX BDSX 70,000 $1.6m0.27% 0.27% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 140.0k, Q2 2026 70.0k -70.0k -70,008 -50.0%
67 TENAX THERAPEUTICS INC COM NEW TENX TENX 96,273 $1.4m0.24% 0.24% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 377.4k, Q2 2026 96.3k -281.1k -281,127 -74.5%
68 SAB BIOTHERAPEUTICS INC COM NEW SABS SABS 342,631 $1.3m0.23% 0.23% ReducedShares held: Q3 2025 0, Q4 2025 146.6k, Q1 2026 750.0k, Q2 2026 342.6k -407.4k -407,369 -54.3%
69 CALCIMEDICA INC COM NEW COM NEW 1,244,864 $1.2m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2m
70 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 31,785 $1.0m0.18% 0.18% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 100.0k, Q2 2026 31.8k -68.2k -68,215 -68.2%
71 CELLECTAR BIOSCIENCES INC COM NEW CLRB CLRB 354,938 $986.7k0.17% 0.17% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 354.9k
72 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 431,054 $801.8k0.14% 0.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 431.1k
73 VISTAGEN THERAPEUTICS INC COM VTGN VTGN 616,749 $17.3k0.00% 0.00% ReducedShares held: Q3 2025 2.5m, Q4 2025 616.7k, Q1 2026 1.2m, Q2 2026 616.7k -616.7k -616,749 -50.0%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
SYNDAX PHARMACEUTICALS INC SNDX SNDX 2,431,486 $56.8m2.4m shares
MBX BIOSCIENCES INC MBX MBX 998,938 $29.8m998.9k shares
DYNE THERAPEUTICS INC DYN DYN 1,012,150 $18.4m1.0m shares
EDGEWISE THERAPEUTICS INC EWTX EWTX 581,728 $18.3m581.7k shares
DENALI THERAPEUTICS INC DNLI DNLI 853,122 $16.4m853.1k shares
NURIX THERAPEUTICS INC NRIX NRIX 630,452 $9.8m630.5k shares
EVOMMUNE INC EVMN EVMN 387,554 $8.8m387.6k shares
FAETH THERAPEUTICS INC FTH FTH 265,746 $8.4m265.7k shares
JOHNSON & JOHNSON JNJ JNJ 30,830 $7.5m30.8k shares
X4 PHARMACEUTICALS INC XFOR XFOR 1,701,484 $7.0m1.7m shares
VAXCYTE INC PCVX PCVX 118,122 $6.9m118.1k shares
INVIVYD INC IVVD IVVD 3,749,092 $4.9m3.7m shares
JADE BIOSCIENCES INC JBIO JBIO 308,068 $4.3m308.1k shares
TWIST BIOSCIENCE CORP TWST TWST 86,220 $4.1m86.2k shares
AVALO THERAPEUTICS INC AVTX AVTX 269,484 $4.0m269.5k shares
IONIS PHARMACEUTICALS INC IONS IONS 52,770 $4.0m52.8k shares
IMMUNOCORE HLDGS PLC IMCR IMCR 127,086 $3.8m127.1k shares
FORTE BIOSCIENCES INC FBRX FBRX 116,040 $3.0m116.0k shares
LIPOCINE INC NEW LPCN LPCN 320,840 $2.6m320.8k shares
EDWARDS LIFESCIENCES CORP EW EW 29,176 $2.3m29.2k shares
CAPRICOR THERAPEUTICS INC CAPR CAPR 75,184 $2.3m75.2k shares
SUTRO BIOPHARMA INC STRO STRO 46,590 $1.2m46.6k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
PERSONALIS INC PSNL · Call PSNLCall 470,000 $810.8k470.0k shares New
BIOHAVEN LTD BHVN · Call BHVNCall 500,000 $525.0k500.0k shares New
SPDR SER TR XBI · Put XBIPut 250,000 $400.0k250.0k shares New
ASTRAZENECA PLC AZN · Call AZNCall 25,000 $180.0k25.0k shares New
SPDR SER TR XBI · Call XBICall 400,000 $178.0k400.0k shares Added
TANGO THERAPEUTICS INC TNGX · Call TNGXCall 100,000 $175.0k100.0k shares New
REVOLUTION MEDICINES INC RVMD · Put RVMDPut 30,000 $127.5k30.0k shares Reduced
ERASCA INC ERAS · Put ERASPut 200,000 $90.0k200.0k shares New
ARK ETF TR ARKG · Put ARKGPut 100,000 $75.0k100.0k shares New
ROIVANT SCIENCES LTD ROIV · Put ROIVPut 100,000 $40.0k100.0k shares New
AMGEN INC AMGN · Put AMGNPut 15,000 $15.0k15.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
CELLECTAR BIOSCIENCES INC CLRB · 13G · filed 2026-08-14 CLRB 9.9%≈ $2.4m new 13G 2026-08-14
XILIO THERAPEUTICS INC XLO · 13G · filed 2026-08-14 XLO 9.5%≈ $5.8m 13G 2026-08-14
XILIO THERAPEUTICS INC 13G · filed 2026-02-17 8.4% +1.2 pts 13G 2026-02-17
SURROZEN INC SRZN · 13G · filed 2026-08-14 SRZN 5.0%≈ $15.6m +0.5 pts 13G 2026-08-14